LDLisa Marie DiFrancesco

Lisa Marie DiFrancesco

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lisa Marie DiFrancesco has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Andrea Kristin Bruecks

    Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada

    1 shared publication
  • Clarissa T. Fauth

    Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada

    1 shared publication
  • John P. Arlette

    Department of General Surgery, University of Calgary, Calgary, Alberta, Canada

    1 shared publication
  • Walley Temple

    Department of General Surgery, University of Calgary, Calgary, Alberta, Canada

    1 shared publication
  • Wenqian Chen

    1 shared publication

Latest Publications

  • Chondroblastoma: An Update

    by Wenqian Chen, Lisa M. DiFrancesco

    Chondroblastoma is a rare primary bone tumor of young people that typically arises in the ends of the long bones. Radiologic investigations show a small, circumscribed, lytic lesion. The tumor is characterized histologically by the proliferation of chondroblasts along with areas of mature cartilage, giant cells, and occasionally, secondary aneurysmal bone cyst formation. Chondroblastoma, however, may also present with atypical features, such as prominent hemosiderin deposition, numerous giant cells, or the presence of a large aneurysmal bone cyst component. Malignant entities such as clear cell chondrosarcoma and chondroblastic osteosarcoma must also be considered. Recently, immunohistochemical stains such as DOG1 and SOX9 have been described in chondroblastoma, and K36M mutations in either the H3F3A or H3F3B genes have also been identified. While generally regarded as a benign entity, chondroblastoma manifests an intermediate type of behavior, given its ability to recur locally, and rarely, metastasize.


  • Superficial leiomyosarcoma: a clinicopathologic review and update

    by Clarissa T. Fauth, Andrea Kristin Bruecks, Walley Temple, John P. Arlette, Lisa Marie DiFrancesco

    Fauth CT, Bruecks AK, Temple W, Arlette JP, DiFrancesco LM. Superficial leiomyosarcoma: a clinicopathologic review and update. Background: Superficial leiomyosarcomas (SLMSs) are rare soft tissue malignancies. A clinicopathologic review of 25 cases was undertaken. Methods: Twenty‐five cases diagnosed between 1990 and 2007 were reviewed. Clinical information was obtained from patient charts. Histologic slides were reviewed, and immunohistochemical stains were performed. Results: All patients presented with a nodule. Fourteen tumors were confined to the dermis and 11 involved subcutaneous tissue. Smooth muscle markers were positive in all cases. CD117 was consistently negative. Novel histological features included epidermal hyperplasia, sclerotic collagen bands and increasing tumor grade with the depth of the lesion. Poor outcome was associated with size > 2 cm, high grade and depth of the lesion. Conclusions: SLMSs are rare but important smooth muscle tumors of the skin. The clinical presentation may be non‐specific. The histologic appearance is that of a smooth muscle lesion, but epidermal hyperplasia and thickened collagen bands are previously underrecognized features. Immunohistochemical stains are useful in confirming smooth muscle differentiation, but CD117 is of limited utility. SLMS can appear low grade or even benign on superficial biopsies, leading to undergrading or a delay in the correct diagnosis. Clinicians and pathologists alike should therefore be aware of these pitfalls and must approach these cases with caution.